Yaz / Yasmin Class Action vs. MDL Consolidation

A panel of judges ordered this week that all federal lawsuits over problems with Yaz and Yasmin birth control pills will be consolidated into an MDL, or multidistrict litigation, for pretrial proceedings in the Southern District of Illinois. Many people equate this with a Yaz / Yasmin class action, but each Yaz lawsuit or Yasmin lawsuit will remain an individual claim and if a settlement is not agreed upon during pretrial litigation, each plaintiff will still have a jury will determine the amount of damages they are entitled to in their case.

JPML LINK (PDF): Yasmin / Yaz MDL Order

Yasmin and Yaz Problems Highlighted by NY Times

An article in the New York Times over the weekend highlights the growing problems with Yaz and Yasmin birth control pills, which may have caused thousands of otherwise healthy young women to suffer serious and potentially life-threatening injuries, such as heart attacks, strokes, deep vein thrombosis (DVT), pulmonary embolism and gallbladder disease.

Yaz / Yasmin Attorneys Set for Hearing on Consolidation of Litigation

Tomorrow, attorneys representing women who have filed a lawsuit over Yaz and Yasmin problems will appear before the United States Judicial Panel on Multidistrict Litigation during hearings to determine whether all cases filed in federal district courts throughout the United States should be consolidated in an MDL for purposes of pretrial litigation.

Read the rest of this entry »

Yasmin and Yaz Recall for Some Batches of Pills Could Be Coming?

The FDA released a warning letter this week sent to Bayer Pharmaceuticals over Yaz and Yasmin problems at the drug makers manufacturing plant in Germany. The letter indicates that Bayer hid out-of-specification test results for key ingredients in the birth control pills and said that several batches of the drugs should have never been released to the public. In what could be a forerunner to a Yasmin and Yaz recall, the FDA has asked for detailed lists of the batches shipped to U.S. customers.

FDA LINK: Warning Letter About Manufacturing Problems with Yaz and Yasmin